- IF2-1 Progress in Clinical Management of H. pylori Infection
Peter Malfertheiner（Department of GastroenterologyHepatology and Infectious DiseasesUniversity of MagdeburgGermany）
The progress in the management of H． pylori infection and related clinical conditions is relentless． Thespectrum of complications includes benign and malignant gastroduodenal pathologies and is relate...
- IF2-2 H. pylori-mediated Gastric Carcinogenesis ； A New Paradigm of Cancer Development
Masanori Hatakeyama（Department of MicrobiologyGraduate School of MedicineThe University of TokyoJapan）
Chronic infection with Helicobac亡er pylori cagA－positive strains is the strongest risk factor fbr the devel－opment of gastric carcinomathe fourth most common cancer and the second leading cause of can...
- IF2-3 Helicobacter pylori CagA Protein Variation Associated with Gastric Cancer
Takeshi Azuma（Department of GastroenterologyKobe University School of MedicineJapan）
CagA is directly inj・ected from the H． pyiori into thecells via the bacterial type IV secretion system andundergoes tyrosine phosphorylation in the host cells． We recently discovered that translocated...